Literature DB >> 10639307

Serum troponins T and I after elective cardioversion.

M Lund1, J K French, R N Johnson, B F Williams, H D White.   

Abstract

AIMS: To describe the pattern of release of five myocardial proteins after elective cardioversion. METHODS AND
RESULTS: We measured serum levels of the myocardial proteins creatine kinase, creatine kinase MB mass, myoglobin, troponin T and troponin I serially from baseline to 24 h after 72 elective cardioversion attempts. The total energy used for attempted cardioversion was 408+/-318 J (range 50 to 1280 J). Maximal creatine kinase levels (median 232 IU x l(-1), interquartile range 91 to 1152 IU x l(-1)) occurred at 24 h and correlated with the total energy delivered (r=0.75, P<0.0001). The peak creatine kinase MB mass levels exceeded the discrimination level for myocardial injury (>/=5 microg x l(-1)) in seven patients (10%). The peak myoglobin levels were elevated (>85 microg x l(-1)) in 40 patients (56%) and correlated with the peak creatine kinase levels (r=0.83, P<0.0001). Troponin T reached the discrimination level (0.10 microg x l(-1)) in one patient with a serum creatinine level of 0.16 mmol x l(-1)and severe left ventricular impairment. Twelve patients had baseline troponin I levels above our prespecified discrimination level of 0.4 microg x l(-1)(range 0.4 to 3.1 microg x l(-1)), which did not increase after cardioversion. In two patients the levels rose from <0.4 microg x l(-1) to 0.5 microg x l(-1) and 0.6 microg x l(-1) respectively.
CONCLUSIONS: Troponin T levels do not rise after elective cardioversion. The minor increases in troponin I may reflect our choice of discrimination level. Cardiac troponins are useful in determining whether arrhythmias requiring emergency cardioversion are primary or secondary to myocardial infarction. Copyright 2000 The European Society of Cardiology.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10639307     DOI: 10.1053/euhj.1999.1745

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  7 in total

Review 1.  Troponin: the biomarker of choice for the detection of cardiac injury.

Authors:  Luciano Babuin; Allan S Jaffe
Journal:  CMAJ       Date:  2005-11-08       Impact factor: 8.262

2.  Comparison of low-energy versus high-energy biphasic defibrillation shocks following prolonged ventricular fibrillation.

Authors:  Gregory P Walcott; Sharon B Melnick; Cheryl R Killingsworth; Raymond E Ideker
Journal:  Prehosp Emerg Care       Date:  2010 Jan-Mar       Impact factor: 3.077

3.  Troponin Marker for Acute Coronary Occlusion and Patient Outcome Following Cardiac Arrest.

Authors:  David A Pearson; Catherine M Wares; Katherine A Mayer; Michael S Runyon; Jonathan R Studnek; Shana L Ward; Kathi M Kraft; Alan C Heffner
Journal:  West J Emerg Med       Date:  2015-12-08

4.  Cardioversion Efficacy Using Pulsed Biphasic or Biphasic Truncated Exponential Waveforms: A Randomized Clinical Trial.

Authors:  Anders S Schmidt; Kasper G Lauridsen; Kasper Adelborg; Peter Torp; Leif F Bach; Simon M Jepsen; Nete Hornung; Charles D Deakin; Hans Rickers; Bo Løfgren
Journal:  J Am Heart Assoc       Date:  2017-03-08       Impact factor: 5.501

5.  Left ventricular dysfunction after two hours of polarizing or depolarizing cardioplegic arrest in a porcine model.

Authors:  Terje Aass; Lodve Stangeland; Christian Arvei Moen; Atle Solholm; Geir Olav Dahle; David J Chambers; Malte Urban; Knut Nesheim; Rune Haaverstad; Knut Matre; Ketil Grong
Journal:  Perfusion       Date:  2018-07-30       Impact factor: 1.972

6.  Tissue suction-mediated gene transfer to the beating heart in mice.

Authors:  Yota Taniguchi; Natsuko Oyama; Shintaro Fumoto; Hideyuki Kinoshita; Fumiyoshi Yamashita; Kazunori Shimizu; Mitsuru Hashida; Shigeru Kawakami
Journal:  PLoS One       Date:  2020-02-06       Impact factor: 3.240

7.  Rhabdomyolysis Causing Renal Failure Following Cardiopulmonary Resuscitation, Cardioversion, and Myocardial Infarction: A Case Report and Review of the Literature.

Authors:  Sonia Gupta; Vinay Kumar Thallapally; Joseph Thirumalareddy
Journal:  Cureus       Date:  2021-01-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.